IMTX
Price
$9.86
Change
+$0.48 (+5.12%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.26B
70 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$9.37
Change
+$0.16 (+1.74%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
801.43M
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMTX vs KURA

Header iconIMTX vs KURA Comparison
Open Charts IMTX vs KURABanner chart's image
Immatics
Price$9.86
Change+$0.48 (+5.12%)
Volume$19.53K
Capitalization1.26B
Kura Oncology
Price$9.37
Change+$0.16 (+1.74%)
Volume$27.35K
Capitalization801.43M
IMTX vs KURA Comparison Chart in %
IMTX
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMTX vs. KURA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (IMTX: $9.38 vs. KURA: $9.21)
Brand notoriety: IMTX and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 54% vs. KURA: 63%
Market capitalization -- IMTX: $1.26B vs. KURA: $801.43M
IMTX [@Biotechnology] is valued at $1.26B. KURA’s [@Biotechnology] market capitalization is $801.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $115.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, KURA is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 3 TA indicator(s) are bullish while KURA’s TA Score has 2 bullish TA indicator(s).

  • IMTX’s TA Score: 3 bullish, 6 bearish.
  • KURA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than KURA.

Price Growth

IMTX (@Biotechnology) experienced а -2.29% price change this week, while KURA (@Biotechnology) price change was -3.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

IMTX is expected to report earnings on Mar 25, 2026.

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.26B) has a higher market cap than KURA($801M). IMTX YTD gains are higher at: -10.667 vs. KURA (-11.357). IMTX has higher annual earnings (EBITDA): -106.34M vs. KURA (-212.24M). KURA has more cash in the bank: 550M vs. IMTX (431M). IMTX has less debt than KURA: IMTX (16.4M) vs KURA (19.5M). KURA has higher revenues than IMTX: KURA (104M) vs IMTX (84.8M).
IMTXKURAIMTX / KURA
Capitalization1.26B801M157%
EBITDA-106.34M-212.24M50%
Gain YTD-10.667-11.35794%
P/E Ratio27.61N/A-
Revenue84.8M104M82%
Total Cash431M550M78%
Total Debt16.4M19.5M84%
FUNDAMENTALS RATINGS
IMTX vs KURA: Fundamental Ratings
IMTX
KURA
OUTLOOK RATING
1..100
5352
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
5052
P/E GROWTH RATING
1..100
67100
SEASONALITY SCORE
1..100
9085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for IMTX (75) in the null industry. This means that KURA’s stock grew somewhat faster than IMTX’s over the last 12 months.

KURA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IMTX (100) in the null industry. This means that KURA’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (96) in the null industry is in the same range as KURA (98) in the Biotechnology industry. This means that IMTX’s stock grew similarly to KURA’s over the last 12 months.

IMTX's Price Growth Rating (50) in the null industry is in the same range as KURA (52) in the Biotechnology industry. This means that IMTX’s stock grew similarly to KURA’s over the last 12 months.

IMTX's P/E Growth Rating (67) in the null industry is somewhat better than the same rating for KURA (100) in the Biotechnology industry. This means that IMTX’s stock grew somewhat faster than KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXKURA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 6 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 24 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
72%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
YACKX23.630.22
+0.94%
AMG Yacktman I
IARCX16.020.10
+0.63%
Invesco Real Estate C
CLTCX15.380.07
+0.46%
Catalyst/Lyons Tactical Allocation C
ALSCX8.120.01
+0.12%
Alger Small Cap Growth B
PENNX9.790.01
+0.10%
Royce Small-Cap Fund Invmt

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+2.40%
IDYA - IMTX
55%
Loosely correlated
-4.75%
XNCR - IMTX
49%
Loosely correlated
-1.62%
SYRE - IMTX
49%
Loosely correlated
-3.87%
VYGR - IMTX
49%
Loosely correlated
+3.08%
KURA - IMTX
49%
Loosely correlated
+0.44%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+0.44%
XNCR - KURA
59%
Loosely correlated
-1.62%
VYGR - KURA
55%
Loosely correlated
+3.08%
NRIX - KURA
55%
Loosely correlated
+2.99%
CLDX - KURA
55%
Loosely correlated
+1.01%
IMNM - KURA
54%
Loosely correlated
-2.09%
More